Lipikar Eczema MED: a medical treatment based on microbiome science

La Roche-Posay launched its Lipikar Eczema MED cream: a medical treatment that combats eczema, a common skin condition among children which manifests as patches of dry, itchy skin. The cream is enriched with endobioma, an ingredient developed thanks to advances in microbiome science. This unique ingredient specifically targets the main bacteria responsible for the inflammation while preserving other bacteria which are essential for healthy skin. Results are visible in just three days. La Roche-Posay laboratories continue to explore the microbiome and harness the latest scientific advances to improve treatment for several skin conditions.